warning icon

COVID-19 DEW Report, powered by Reformulary®Read more

@var craft \craft\web\twig\variables\CraftVariable Header

Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ over safety concern

A clinical trial of US-based drug manufacturer Eli Lilly & Co’s COVID-19 antibody treatment has been suspended following a reported safety concern. The drug, LY-CoV555, is undergoing a 10,000 participant government-sponsored study called ACTIV-3; an independent safety panel advised the pause. The antibody treatment is being tested in hospitalized COVID-19 patients, and in nursing homes to determine if it can prevent infection in those settings.

Published: October 13, 2020

Yahoo! Finance

Read Article